Bioasis Technologies Inc. Stock
Stocks
BIOAF
CA09064N1033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:29:06 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | +9,900.00% |
| Current year | +9,900.00% |
| Market Cap | 1.56M 1.09M 976K 910K 827K 106M 1.57M 10.93M 4.27M 53.77M 4.1M 4.01M 173M | P/E 2021 |
37.2x | P/E 2022 | -6.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.73M 1.21M 1.08M 1.01M 918K 117M 1.74M 12.13M 4.74M 59.68M 4.55M 4.45M 192M | EV / Sales 2021 |
6.07x | EV / Sales 2022 | 516x |
| Free-Float |
97.95% | Yield 2021 * |
-
| Yield 2022 | - |
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.01 |
| 5 years | 0 | | 0.28 |
| 10 years | 0 | | 1.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 2019-03-10 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 2021-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/23 | Option | Director | 250,000 | 0.3148% | ||
| 6/9/23 | Option | Director | 250,000 | 0.3148% | ||
| 6/9/23 | Option | Director | 250,000 | 0.3148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -50.00% | -98.20% | 7.94K | |
| -3.19% | -3.19% | +44.60% | +87.98% | 72.13B | |
| +4.59% | -10.06% | +5.59% | +57.04% | 49.41B | |
| +1.37% | +0.50% | +3.41% | +31.33% | 47.24B | |
| -6.35% | -8.63% | +293.39% | +651.28% | 40.32B | |
| +0.30% | -0.71% | +29.05% | +30.33% | 42.61B | |
| -3.82% | -2.41% | -0.27% | +101.36% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| -3.35% | -4.95% | -13.38% | -17.22% | 23.13B | |
| +2.48% | +1.86% | +12.19% | -5.34% | 21.09B | |
| Average | -1.12% | -3.29% | +33.21% | +88.89% | 36.63B | |
| Weighted average by Cap. | -1.27% | -3.85% | +46.11% | +118.10% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4.08M 2.86M 2.56M 2.39M 2.17M 277M 4.12M 28.64M 11.2M 141M 10.75M 10.52M 453M | 37.72K 26.49K 23.66K 22.07K 20.05K 2.57M 38.09K 265K 104K 1.3M 99.47K 97.31K 4.19M |
| Net income | 698K 490K 438K 409K 371K 47.5M 705K 4.91M 1.92M 24.14M 1.84M 1.8M 77.63M | -2.96M -2.08M -1.86M -1.73M -1.57M -201M -2.99M -20.79M -8.13M -102M -7.8M -7.64M -329M |
| Net Debt | -2.62M -1.84M -1.64M -1.53M -1.39M -178M -2.65M -18.42M -7.21M -90.66M -6.92M -6.77M -292M | 171K 120K 107K 100K 90.87K 11.63M 173K 1.2M 470K 5.91M 451K 441K 19.01M |
Employees
-
- Stock Market
- Stocks
- BIOAF Stock
Select your edition
All financial news and data tailored to specific country editions
